ICR Launches New Guide to the EU Directives
The Institute of Clinical Research (ICR) is continuing its work to promote understanding and raise standards in clinical research with the publication of a new book on the EU Directives.
The Pocket Guide to the EU Directives for Clinical Research provides a summary of the key aspects of the Clinical Trials Directive 2001/20/EC, Good Clinical Practice Directive 2005/28/EC and Good Manufacturing Practice Directive 2003/94/EC. The publication is designed to be read in conjunction with the Directives themselves and provides a useful, easy to read overview.
This compact guide is written by Dr Julie Meeson FICR, a quality assurance consultant who also runs her own company providing quality assurance and training services to pharmaceutical companies and CROs. Julie commented "The EU Directives are critical documents for all clinical research professionals but can be difficult for many to understand.
"The three Directives cover the most extensive changes in European Union clinical trial legislation and our new book will help clinical research professionals better understand and use the Directives in their work."
Another recent addition to the ICR's extensive range of clinical research booklets and monographs is The ICR Guide to Freelancing, which highlights the benefits and pitfalls of freelancing and provides useful tips for starting out on your own.
For corporate and bulk purchases, the ICR can provide ICH GCP and Fundamental Guidelines booklets with customised covers, which can be distributed to staff as part of their continuing professional development or during training courses.
The Pocket Guide to the EU Directives for Clinical Research (ISBN: 9 781905 238675) is priced at £17.00 and is available for purchase via the online shop or from other online booksellers. For further information log on to the ICR website at www.icr-global.org/resources/publications/.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
SOUL Trial Shows Oral Semaglutide Significantly Reduces Cardiovascular Risk in Type 2 Diabetes
April 3rd 2025Phase III SOUL trial shows daily oral semaglutide lowers the risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease, with benefits consistent with injectable semaglutide and other GLP-1 receptor agonists.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
